N
Nyxoah SA (NYXH)
NGM – Real Time Price. Currency in USD
3.07
-0.28 (-8.36%)
At close: May 12, 2026, 4:00 PM EDT
3.26
+0.19 (6.19%)
After-hours: May 12, 2026, 7:41 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
3.07
-0.28 (-8.36%)
At close: May 12, 2026, 4:00 PM EDT
3.26
+0.19 (6.19%)
After-hours: May 12, 2026, 7:41 PM EDT
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
| Name | Position |
|---|---|
| Mr. Bruno Onkelinx | Chief Technical Officer |
| Mr. Jeyakumar Subbaroyan | Chief Science Officer |
| Mr. John Landry | Chief Financial Officer |
| Mr. Loic Moreau | President of International |
| Mr. Olivier Taelman | CEO & Executive Director |
| Mr. Robert Taub MBA | Co-Founder & Chairman |
| Ms. An Moonen | General Counsel |
| Ms. Geeta Kaveti | Chief Compliance Officer |
| Ms. Maggie McGowan | Chief HR Officer |
| Pearson Dennis | Investor Relations Associate |
| Date | Type | Document |
|---|---|---|
| 2026-03-26 | S-8 | tm268441d1_s8.htm |
| 2026-03-26 | 20-F | nyxh-20251231x20f.htm |
| 2026-03-19 | 6-K | tm269369d1_6k.htm |
| 2026-01-30 | 6-K | tm264577d1_6k.htm |
| 2026-01-14 | 6-K | tm263102d1_6k.htm |
| 2025-12-19 | 6-K | tm2533876d1_6k.htm |
| 2025-12-05 | 6-K | tm2532854d1_6k.htm |
| 2025-11-13 | 6-K | tm2531060d1_6k.htm |
| 2025-09-24 | 6-K/A | tm2510209d4_6ka.htm |
| 2025-09-24 | 6-K | tm2526703d1_6k.htm |